Cord Blood Stem Cell Banking has emerged as new opportunity of healthcare services provider in Indian market. The market is still in nascent stage of development and valued around US$ 60 Million in 2013 and further expected to surpass US$ 400 Million by 2018. The current cord blood stem cell preservation level for new born baby is below 1% and hence there exists immense opportunity for cord blood stem cell preservation service providers to grow exponentially in coming years. With more than 20 million births every year there exist ample market opportunity for large number of cord blood stem cells banks to enter Indian stem cell preservation market and expand their services portfolio. The market potential of cord blood stem cell banking in India is valued at more than US$ 350 Million at preservation level of 1% which can increase to more than US$ 1 Billion at stem cell preservation level of 3% for new born babies.
Many factors have actively contributing towards this overwhelming success cord blood stem cell banking in India and one of the major reasons for its success has been collaborations. Apart from handling the main stage single handedly, much collaboration both national and international has come to meet this upsurge. Growth in this sector can further be enhanced based on increased percolation of the middle class, which is thought to possess largest spending power, defined regulatory framework to help ensure that ethics and morals are well considered and complicate is ensured for maintaining quality parameters.
India is poised to emerge as the largest source for umbilical cord blood given the very high birth rate in the world. Since umbilical cords are the richest source of stem cells, it's no surprise then that leading stem cell banking companies are keen on shifting their stem cell bases in India. Till date around six major private players, both Indian as well subsidiaries of international companies are operating in the stem cell banking market of India.
“India Cord Blood Stem Cell Banking Market” research report outlines following aspects related to booming stem cell banking in India:
India Stem Cell Research & Therapy Market Overview Cord Blood Stem Cell Banking Market Overview Market Dynamics & Cost Analysis Future Growth Avenues Preferred Business Model for Cord Blood Stem Cell Banks Regulatory & Policy Framework Institutional Support Framework Competitive Landscape
Our reports have been used by over 10K customers, including:
Transplant Complications Drug Development Pipeline Review, 2018 Summary GVHD is a complication that can occur after a stem cell or bone marrow transplant and involves the newly transplanted donor cells attacking the transplant recipient’s body. Symptoms include abdominal pain or cramps, nausea, vomiting,...
201 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Jan 2019
Cell lines are one the major tools used in research for studying the normal physiology and biochemistry of cells, the effects of drugs and toxic compounds on the cells, drug screening and development and large scale manufacturing of biological compounds. Cell culture is the process by which cells are grown under controlled...
Bronchiolitis Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Bronchiolitis Global Clinical Trials Review, H2, 2018" provides an overview of Bronchiolitis clinical trials scenario.This report provides top line data relating to the clinical trials on Bronchiolitis. Report...
Chondrosarcoma Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Chondrosarcoma Global Clinical Trials Review, H2, 2018" provides an overview of Chondrosarcoma clinical trials scenario.This report provides top line data relating to the clinical trials on Chondrosarcoma. Report...
204 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Dec 2018
The contract biomanufacturing global market is expected to grow at double digit CAGR to reach $48.8 billion by 2027. Biomanufacturing is a widely used term to describe the manufacture of biologic molecules for various stages of drug development right from pre-clinical stage to commercial supply. The biologic drug manufacturing...
Global Recombinant Cell Culture Supplements Market to Reach $788.6 million by 2028, BIS Research Report The process of cell culture involves the growth or proliferation of cells extracted from plant or animal sources under controlled conditions in an artificial media.Cell culture is an integral part of biotechnology...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.